Back to News
Market Impact: 0.75

Reckitt shares surge 9% as upgraded outlook and profit growth boost confidence

RKT
Corporate Guidance & OutlookCorporate EarningsCapital Returns (Dividends / Buybacks)Company FundamentalsEmerging MarketsHealthcare & BiotechConsumer Demand & Retail
Reckitt shares surge 9% as upgraded outlook and profit growth boost confidence

Reckitt Benckiser Group PLC shares surged 9% after the company upgraded its 2025 outlook and reported strong first-half results, signaling renewed confidence post-transformation. The new guidance projects 3-4% like-for-like net revenue growth for the year, underpinned by a 4.2% H1 core Reckitt LFL revenue increase, particularly from emerging markets. Adjusted operating profit rose 7% to £1.7 billion, boosting the operating margin by 1.1 percentage points to 24.6%, while adjusted EPS increased 4.4%. Concurrently, Reckitt raised its interim dividend by 5% and launched a new £1 billion share buyback, reflecting a strategic focus on efficiency and capital return.

Analysis

Reckitt Benckiser Group PLC (RKT) experienced a 9% share price increase following an upgraded full-year 2025 outlook, which now projects 3-4% like-for-like net revenue growth. This enhanced guidance is supported by a strong first-half performance where the core Reckitt business saw LFL net revenue rise by 4.2%, driven by exceptional growth of nearly 13% in emerging markets. The company's strategic focus on cost efficiency and its Powerbrands portfolio has demonstrably improved profitability, lifting the adjusted operating margin by 1.1 percentage points to 24.6% and increasing adjusted operating profit by 7% to £1.7 billion at constant exchange rates. This operational strength translated into a 4.4% rise in diluted adjusted EPS. While adverse currency movements caused total reported net revenue to decline 2.6% to just under £7 billion, the company's confidence is underscored by a 5% increase in the interim dividend and the launch of a new £1 billion share buyback program, signaling a successful phase in its transformation into a more focused health and hygiene entity.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.